These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10624555)

  • 1. Behavioral, neuroendocrine, and cardiovascular response to flumazenil: no evidence for an altered benzodiazepine receptor sensitivity in panic disorder.
    Potokar J; Lawson C; Wilson S; Nutt D
    Biol Psychiatry; 1999 Dec; 46(12):1709-11. PubMed ID: 10624555
    [No Abstract]   [Full Text] [Related]  

  • 2. Behavioral, neuroendocrine, and cardiovascular response to flumazenil: no evidence for an altered benzodiazepine receptor sensitivity in panic disorder.
    Ströhle A; Kellner M; Holsboer F; Wiedemann K
    Biol Psychiatry; 1999 Feb; 45(3):321-6. PubMed ID: 10023509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzodiazepine receptor sensitivity in panic disorder.
    Glue P; Nutt DJ
    Lancet; 1991 Mar; 337(8740):563. PubMed ID: 1671933
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of the benzodiazepine antagonist flumazenil in PTSD.
    Randall PK; Bremner JD; Krystal JH; Nagy LM; Heninger GR; Nicolaou AL; Charney DS
    Biol Psychiatry; 1995 Sep; 38(5):319-24. PubMed ID: 7495926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral, biochemical, and cardiovascular responses to the benzodiazepine receptor antagonist flumazenil in panic disorder.
    Woods SW; Charney DS; Silver JM; Krystal JH; Heninger GR
    Psychiatry Res; 1991 Feb; 36(2):115-27. PubMed ID: 1850142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of low-dose flumazenil in panic disorder.
    Maddock RJ
    J Clin Psychopharmacol; 1998 Jun; 18(3):258-61. PubMed ID: 9617991
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of flumazenil on cholecystokinin-tetrapeptide-induced panic symptoms in healthy volunteers.
    Bradwejn J; Koszycki D; Couëtoux du Tertre A; Paradis M; Bourin M
    Psychopharmacology (Berl); 1994 Mar; 114(2):257-61. PubMed ID: 7838917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder.
    Nutt DJ; Glue P; Lawson C; Wilson S
    Arch Gen Psychiatry; 1990 Oct; 47(10):917-25. PubMed ID: 2171449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic use of alcohol and/or benzodiazepines may account for evidence of altered benzodiazepine receptor sensitivity in panic disorder.
    Stewart SH; Pihl RO; Padjen AL
    Arch Gen Psychiatry; 1992 Apr; 49(4):329-32. PubMed ID: 1313670
    [No Abstract]   [Full Text] [Related]  

  • 10. Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study.
    Malizia AL; Cunningham VJ; Bell CJ; Liddle PF; Jones T; Nutt DJ
    Arch Gen Psychiatry; 1998 Aug; 55(8):715-20. PubMed ID: 9707382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzodiazepine receptor antagonist (flumazenil) does not affect sleep-related breathing disorders.
    Schönhofer B; Köhler D
    Eur Respir J; 1996 Sep; 9(9):1816-20. PubMed ID: 8880096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flumazenil pretreatment in benzodiazepine-free patients: a novel method for managing declining ECT seizure quality.
    Yi J; Torres J; Azner Y; Vaidya P; Schiavi A; Reti IM
    J ECT; 2012 Sep; 28(3):185-9. PubMed ID: 22513511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evoked potentials and the effect of flumazenil in patients with liver cirrhosis.
    Ozyilkan E; Kahraman H; Onar M; Kesim G; Arik Z
    East Afr Med J; 1997 Apr; 74(4):210-2. PubMed ID: 9299818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of flumazenil in lactate-sensitive patients with panic disorder.
    Ströhle A; Kellner M; Yassouridis A; Holsboer F; Wiedemann K
    Am J Psychiatry; 1998 May; 155(5):610-2. PubMed ID: 9585710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to flumazenil in the late luteal phase and follicular phase of the menstrual cycle in healthy control females.
    Bell EC; Baker GB; Poag C; Bellavance F; Khudabux J; Le Mellédo JM
    Psychopharmacology (Berl); 2004 Mar; 172(3):248-54. PubMed ID: 14712334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPECT [I-123]iomazenil measurement of the benzodiazepine receptor in panic disorder.
    Bremner JD; Innis RB; White T; Fujita M; Silbersweig D; Goddard AW; Staib L; Stern E; Cappiello A; Woods S; Baldwin R; Charney DS
    Biol Psychiatry; 2000 Jan; 47(2):96-106. PubMed ID: 10664825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study of the behavioral effects of flumazenil in two children with autism.
    Wray JA; Yoon JH; Vollmer T; Mauk J
    J Autism Dev Disord; 2000 Dec; 30(6):619-20. PubMed ID: 11261474
    [No Abstract]   [Full Text] [Related]  

  • 18. Altered cerebral gamma-aminobutyric acid type A-benzodiazepine receptor binding in panic disorder determined by [11C]flumazenil positron emission tomography.
    Hasler G; Nugent AC; Carlson PJ; Carson RE; Geraci M; Drevets WC
    Arch Gen Psychiatry; 2008 Oct; 65(10):1166-75. PubMed ID: 18838633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of GABAA receptors for the pathophysiology and therapy of panic disorders].
    Rupprecht R; Zwanzger P
    Nervenarzt; 2003 Jul; 74(7):543-51. PubMed ID: 12861364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of hepatic encephalopathy with flumazenil].
    Elkjaer JM; Jensen TU; Emborg J
    Ugeskr Laeger; 2000 Aug; 162(35):4681-4. PubMed ID: 10986901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.